GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apellis Pharmaceuticals Inc (STU:1JK) » Definitions » Other Liabilities for Insurance Companies

Apellis Pharmaceuticals (STU:1JK) Other Liabilities for Insurance Companies


View and export this data going back to 2023. Start your Free Trial

What is Apellis Pharmaceuticals Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Apellis Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
100 Fifth Avenue, Waltham, MA, USA, 02451
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.